Nate Barrall, Associate Director for Market Insights and Strategy at CSL Seqirus, brings robust analytical and strategic skills honed from his tenure at both CSL Seqirus and IQVIA CI. Known for translating complex data into actionable insights, Nate shapes business growth through competitive analysis, market segmentation, and customer profiling. His strategic acumen helps businesses understand their market position and identify opportunities. A lifelong learner, Nate values curiosity and innovation, fostering an environment conducive to creative thinking. His blend of rigorous analysis and strategic vision makes him an integral asset in the dynamic field of market insights and strategy.

o CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis, and nephrology. Founded in 1916, CSL has been driven by the promise to save lives using the latest technologies. Today, CSL – including CSL Behring, CSL Seqirus, CSL Plasma, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. The unique combination of commercial strength, R&D focus, and operational excellence enables CSL to identify, develop, and deliver innovations so patients can live life to the fullest. Find out more at www.csl.com.